Variant report

Variant	esv14170
Chromosome Location	chr19:51891298-51892818
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:46)
CpG islands
(count:244)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:46 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:51891322-51891524	HepG2	liver:	n/a	n/a
2	BCL3	chr19:51891282-51891661	GM12878	blood:	n/a	n/a
3	BCL3	chr19:51891278-51891697	GM12878	blood:	n/a	n/a
4	CEBPD	chr19:51892371-51892653	HepG2	liver:	n/a	n/a
5	CEBPD	chr19:51891329-51891573	HepG2	liver:	n/a	n/a
6	EGR1	chr19:51891277-51891491	GM12878	blood:	n/a	chr19:51891390-51891404 chr19:51891393-51891406 chr19:51891387-51891397 chr19:51891392-51891407 chr19:51891394-51891405 chr19:51891388-51891403
7	EGR1	chr19:51891290-51891507	GM12878	blood:	n/a	chr19:51891390-51891404 chr19:51891393-51891406 chr19:51891387-51891397 chr19:51891392-51891407 chr19:51891394-51891405 chr19:51891388-51891403
8	EP300	chr19:51892808-51892907	HepG2	liver:	n/a	n/a
9	FOXA1	chr19:51891290-51891606	HepG2	liver:	n/a	n/a
10	FOXA1	chr19:51891341-51891727	HepG2	liver:	n/a	n/a
11	FOXA1	chr19:51891313-51891692	HepG2	liver:	n/a	n/a
12	FOXA1	chr19:51891337-51891738	HepG2	liver:	n/a	n/a
13	FOXA2	chr19:51891329-51891597	HepG2	liver:	n/a	n/a
14	HEY1	chr19:51892275-51892778	HepG2	liver:	n/a	chr19:51892382-51892397
15	MAFF	chr19:51891250-51891561	HepG2	liver:	n/a	n/a
16	MAFK	chr19:51891221-51891560	HepG2	liver:	n/a	n/a
17	MAFK	chr19:51891366-51891526	HepG2	liver:	n/a	n/a
18	MAX	chr19:51892147-51892841	HepG2	liver:	n/a	n/a
19	MAX	chr19:51892595-51892732	HepG2	liver:	n/a	n/a
20	MAZ	chr19:51892442-51892692	HepG2	liver:	n/a	n/a
21	MYBL2	chr19:51891256-51891640	HepG2	liver:	n/a	n/a
22	MYC	chr19:51892477-51892581	HepG2	liver:	n/a	n/a
23	MYC	chr19:51892583-51892588	HepG2	liver:	n/a	n/a
24	PBX3	chr19:51891437-51891623	GM12878	blood:	n/a	n/a
25	POLR2A	chr19:51892424-51892762	HepG2	liver:	n/a	n/a
26	POLR2A	chr19:51892538-51892748	HepG2	liver:	n/a	n/a
27	POLR2A	chr19:51892273-51892739	HepG2	liver:	n/a	n/a
28	POLR2A	chr19:51891753-51891763	HepG2	liver:	n/a	n/a
29	POLR2A	chr19:51891448-51891661	MCF-7	breast:	n/a	n/a
30	POLR2A	chr19:51892413-51892689	HepG2	liver:	n/a	n/a
31	POLR2A	chr19:51892370-51892750	HepG2	liver:	n/a	n/a
32	POLR2A	chr19:51892101-51892564	K562	blood:	n/a	n/a
33	POLR2A	chr19:51892553-51892769	HepG2	liver:	n/a	n/a
34	POLR2A	chr19:51891524-51891674	HepG2	liver:	n/a	n/a
35	RAD21	chr19:51892574-51892592	HepG2	liver:	n/a	n/a
36	RELA	chr19:51891270-51891667	GM12891	blood:	n/a	n/a
37	RUNX3	chr19:51891885-51892135	GM12878	blood:	n/a	chr19:51892107-51892116 chr19:51892107-51892116
38	RUNX3	chr19:51891956-51892174	GM12878	blood:	n/a	chr19:51892107-51892116 chr19:51892107-51892116
39	RUNX3	chr19:51891260-51891518	GM12878	blood:	n/a	n/a
40	TAF1	chr19:51892313-51892734	HepG2	liver:	n/a	n/a
41	TCF3	chr19:51891321-51891602	GM12878	blood:	n/a	n/a
42	YY1	chr19:51891264-51891692	HepG2	liver:	n/a	n/a
43	YY1	chr19:51892316-51892830	HepG2	liver:	n/a	chr19:51892381-51892395
44	ZBTB7A	chr19:51892359-51892524	K562	blood:	n/a	chr19:51892379-51892387
45	ZBTB7A	chr19:51892343-51892549	HepG2	liver:	n/a	chr19:51892379-51892387
46	ZEB1	chr19:51891367-51891748	GM12878	blood:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:51891526-51891576	HCT-116	colon:	n/a
2	chr19:51891339-51891389	PANC-1	pancreas:	n/a
3	chr19:51891526-51891576	NHDF-neo	bronchial:	n/a
4	chr19:51892299-51892349	GM12892	blood:	n/a
5	chr19:51892428-51892478	H1-hESC	embryonic stem cell:	embryo
6	chr19:51892428-51892478	HRPEpiC	eye:	n/a
7	chr19:51892299-51892349	MCF-7	breast:	n/a
8	chr19:51891339-51891389	NT2-D1	testis:	n/a
9	chr19:51892299-51892349	HMEC	breast:	n/a
10	chr19:51892428-51892478	ovcar-3	ovarian:	n/a
11	chr19:51891339-51891389	HRCEpiC	kidney:	n/a
12	chr19:51892299-51892349	HAEpiC	amniotic membrane:	n/a
13	chr19:51891339-51891389	HCPEpiC	choroid plexus:	n/a
14	chr19:51891339-51891389	HRPEpiC	eye:	n/a
15	chr19:51891339-51891389	HIPEpiC	eye:	n/a
16	chr19:51892428-51892478	HL-60	blood:	n/a
17	chr19:51892428-51892478	NB4	blood:	n/a
18	chr19:51891526-51891576	AG04450	lung:	fetal
19	chr19:51891339-51891389	NHDF-neo	bronchial:	n/a
20	chr19:51892299-51892349	ECC-1	luminal epithelium:	n/a
21	chr19:51892428-51892478	HAEpiC	amniotic membrane:	n/a
22	chr19:51891526-51891576	HRCEpiC	kidney:	n/a
23	chr19:51892299-51892349	NH-A	brain:	n/a
24	chr19:51892299-51892349	HRCEpiC	kidney:	n/a
25	chr19:51891339-51891389	AG10803	skin:	n/a
26	chr19:51891526-51891576	AG09319	gingival:	n/a
27	chr19:51892299-51892349	Caco-2	colon:	n/a
28	chr19:51892428-51892478	RPTEC	kidney:	n/a
29	chr19:51891339-51891389	GM06990	blood:	n/a
30	chr19:51891339-51891389	NB4	blood:	n/a
31	chr19:51892299-51892349	HUVEC	blood vessel:	n/a
32	chr19:51891526-51891576	GM12892	blood:	n/a
33	chr19:51891339-51891389	HNPCEpiC	eye:	n/a
34	chr19:51892428-51892478	Hepatocyte	liver:	n/a
35	chr19:51891339-51891389	PrEC	prostate:	n/a
36	chr19:51891526-51891576	HEK293	kidney:	embryo
37	chr19:51892299-51892349	BJ	skin:	n/a
38	chr19:51891526-51891576	HIPEpiC	eye:	n/a
39	chr19:51891526-51891576	GM19239	blood:	n/a
40	chr19:51892299-51892349	A549	lung:	n/a
41	chr19:51891339-51891389	LNCaP	prostate:	n/a
42	chr19:51892428-51892478	HRE	kidney:	n/a
43	chr19:51892428-51892478	Hela-S3	cervix:	n/a
44	chr19:51892299-51892349	GM12891	blood:	n/a
45	chr19:51891339-51891389	SK-N-SH_RA	brain:	n/a
46	chr19:51892428-51892478	NHBE	bronchial:	n/a
47	chr19:51892428-51892478	BE2_C	brain:	n/a
48	chr19:51891339-51891389	U87	brain:	n/a
49	chr19:51892428-51892478	AG10803	skin:	n/a
50	chr19:51892299-51892349	H1-hESC	embryonic stem cell:	embryo

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:51889722..51893942-chr19:51894149..51900029,8	K562	blood:
2	chr19:51864453..51872845-chr19:51892428..51902096,29	K562	blood:
3	chr19:51859965..51862618-chr19:51891276..51893885,2	K562	blood:
4	chr19:51867909..51871447-chr19:51887318..51891818,5	K562	blood:
5	chr19:51841717..51843747-chr19:51891710..51894546,2	K562	blood:
6	chr19:51840838..51845657-chr19:51892354..51900411,18	K562	blood:
7	chr19:51889349..51894566-chr19:51895156..51899826,6	K562	blood:
8	chr19:51867772..51875803-chr19:51892381..51899756,21	K562	blood:
9	chr19:51867909..51871717-chr19:51887380..51891573,4	K562	blood:

No data

Variant related genes	Relation type
ENSG00000268889	TF binding region
LIM2	TF binding region
ENSG00000268889	CpG island
LIM2	CpG island
ENSG00000186806	chromatin interactions
ENSG00000160318	chromatin interactions
ENSG00000105374	chromatin interactions
ENSG00000267905	chromatin interactions
ENSG00000269403	chromatin interactions
ENSG00000268520	chromatin interactions
ENSG00000105379	chromatin interactions
ENSG00000268889	chromatin interactions

Extended variants
information (count: 80 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:80 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs373830998	chr19:51891298-51891299	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
2	rs375790182	chr19:51891373-51891374	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
3	rs147834355	chr19:51891395-51891396	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
4	rs574775609	chr19:51891426-51891427	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
5	rs369995933	chr19:51891440-51891441	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
6	rs73562111	chr19:51891463-51891464	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
7	rs76450697	chr19:51891466-51891467	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
8	rs199866620	chr19:51891494-51891495	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
9	rs374649689	chr19:51891495-51891496	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
10	rs554249839	chr19:51891500-51891501	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
11	rs200289170	chr19:51891501-51891502	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
12	rs146045136	chr19:51891502-51891503	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
13	rs569971313	chr19:51891503-51891504	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
14	rs572487263	chr19:51891509-51891510	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
15	rs546350809	chr19:51891513-51891514	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
16	rs200994522	chr19:51891517-51891518	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
17	rs564687059	chr19:51891526-51891527	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
18	rs375843435	chr19:51891529-51891530	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
19	rs544123084	chr19:51891532-51891533	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
20	rs112777610	chr19:51891536-51891537	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
21	rs140281973	chr19:51891537-51891538	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
22	rs3810092	chr19:51891557-51891558	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
23	rs62114205	chr19:51891603-51891604	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
24	rs3810093	chr19:51891628-51891629	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs532898451	chr19:51891640-51891641	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
26	rs551118929	chr19:51891644-51891645	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
27	rs569516510	chr19:51891668-51891669	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
28	rs150437098	chr19:51891697-51891698	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
29	rs377432294	chr19:51891734-51891735	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
30	rs548857999	chr19:51891740-51891741	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
31	rs567485482	chr19:51891743-51891744	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
32	rs73562113	chr19:51891744-51891745	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	7 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs553900864	chr19:51891762-51891763	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
34	rs145263477	chr19:51891795-51891796	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
35	rs182291045	chr19:51891814-51891815	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
36	rs3826657	chr19:51891848-51891849	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
37	rs113716094	chr19:51891851-51891852	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs185252273	chr19:51891857-51891858	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs3826658	chr19:51891874-51891875	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs544064484	chr19:51891902-51891903	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs3826659	chr19:51891909-51891910	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs376903054	chr19:51891920-51891921	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs574270998	chr19:51891958-51891959	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs540984523	chr19:51891969-51891970	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs3826660	chr19:51891982-51891983	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
46	rs190103381	chr19:51892006-51892007	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs533108166	chr19:51892015-51892016	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs369456286	chr19:51892016-51892017	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs3826662	chr19:51892017-51892018	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
50	rs532011059	chr19:51892024-51892025	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Adrenocortical carcinoma	18281524	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ovarian cancer	21781307	CNVD
Neuroblastoma	20406844	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:38 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:51872000-51897000	Weak transcription	Right Atrium	heart
2	chr19:51887800-51893400	Weak transcription	Primary neutrophils fromperipheralblood	blood
3	chr19:51889200-51893600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
4	chr19:51889200-51893800	Weak transcription	GM12878-XiMat	blood
5	chr19:51889200-51897000	Weak transcription	Spleen	Spleen
6	chr19:51889400-51893000	Weak transcription	K562	blood
7	chr19:51890200-51891800	Flanking Active TSS	Primary T cells fromperipheralblood	blood
8	chr19:51890200-51892600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
9	chr19:51890200-51893000	Flanking Active TSS	HepG2	liver
10	chr19:51890200-51893200	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
11	chr19:51890400-51891800	Active TSS	Primary mononuclear cells fromperipheralblood	Blood
12	chr19:51890400-51892000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr19:51890600-51891800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr19:51890800-51891600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
15	chr19:51890800-51892400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
16	chr19:51891000-51894400	Weak transcription	Primary T helper naive cells from peripheral blood	blood
17	chr19:51891000-51897000	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
18	chr19:51891200-51891600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr19:51891200-51892600	Enhancers	Fetal Intestine Small	intestine
20	chr19:51891200-51894200	Weak transcription	Primary T killer memory cells from peripheral blood	blood
21	chr19:51891400-51891800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
22	chr19:51891400-51891800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr19:51891600-51892000	Enhancers	iPS-15b Cell Line	embryonic stem cell
24	chr19:51891600-51892400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr19:51891600-51892600	Enhancers	Fetal Intestine Large	intestine
26	chr19:51891600-51897000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
27	chr19:51891800-51892800	Enhancers	Primary T cells fromperipheralblood	blood
28	chr19:51891800-51894000	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
29	chr19:51891800-51897000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
30	chr19:51891800-51897000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
31	chr19:51891800-51897000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
32	chr19:51892000-51893400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
33	chr19:51892400-51894200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr19:51892400-51894200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
35	chr19:51892600-51893600	Flanking Active TSS	Fetal Intestine Large	intestine
36	chr19:51892600-51893600	Enhancers	Fetal Thymus	thymus
37	chr19:51892600-51894800	Active TSS	Fetal Intestine Small	intestine
38	chr19:51892600-51897000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links